«Factor Ixa

Below is an extended Factor Ixa patents listing. Click here to return to the Factor Ixa main in depth entry.

Patents :
US Patent No.	Title
7279161	Factor IX/factor IXa activating antibodies and antibody derivatives
7314874	Benzamides and related inhibitors of factor Xa
7314917	Modified vitamin K-dependent polypeptides
7332283	Fluorescence based biosensor
7335504	Engineered enzymes and uses thereof
7338963	Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
7342013	Benzamides and related inhibitors of factor Xa
7342014	Diamine derivatives
7348004	Immunoglobulin chimeric monomer-dimer hybrids
7351822	Serine protease inhibitors
7354585	Methods of treating coagulapathic or thrombotic disorders
7312325	RNA aptamers and methods for identifying the same
7312235	Benzamide inhibitors of factor Xa
7312218	Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
7285565	Benzamides and related inhibitors of factor Xa
7285631	Human cDNAs and proteins and uses thereof
7285635	Modified proteins, designer toxins, and methods of making thereof
7291587	Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides
7294699	Modified vitamin K-dependent polypeptides
7297336	Factor IXa specific antibodies displaying factor VIIIa like activity
7300922	Modulators of pharmacological agents
7304041	Modulators of coagulation factors
7308303	Thrombolysis and chronic anticoagulation therapy
7312214	1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors
7354897	Method and composition for inhibiting or slowing blood coagulation
7357916	Method for creating a uniform vascular wound in zebrafish or zebrafish larva
7381732	Pyrazolobenzamides and derivatives as factor Xa inhibitors
7384909	Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents
7388096	Crystalline forms of a factor Xa inhibitor
7392140	Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
7404956	Immunoglobulin chimeric monomer-dimer hybrids
7416860	Nucleic acids encoding human coagulation factor VII variants
7416861	Human coagulation factor VII polypeptides
7417063	Bicyclic heterocycles useful as serine protease inhibitors
7419803	Nucleic acids encoding human coagulation Factor VII polypeptides
7419948	Treatment of hemophilia with human Factor IX produced in mammary tissue of transgenic mammals
7381408	Methods for chemically synthesizing immunoglobulin chimeric proteins
7378393	Recombinant anticoagulant proteins
7378386	Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives
7358055	Diagnostic markers of acute coronary syndrome and methods of use thereof
7361473	Diagnostic markers of acute coronary syndrome and methods of use thereof
7361485	Method for the detection of proteolytic enzymes
7364735	Method for diagnosis and treatment of haemophilia A patients with an inhibitor
7371722	Pharmaceutical preparations and medicine capable of generating and/or containing thrombin
7371729	Boronic acid salts useful in parenteral formulations
7371743	Carboxylic acid amides, the preparation thereof and their use as medicaments
7371761	Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
7371864	Crystalline forms of a factor Xa inhibitor
7375084	Highly phosphorylated and sulfated recombinant factor IX
7419949	Single-dose administration of factor VIIa

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.